annb0t
Top 20
MELBOURNE, Australia, July 24, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX) (Telix, the Company, the Issuer) is pleased to announce that it has successfully priced A$650 million 2.375 per cent convertible notes due 2029. The convertible notes, also referred to as "convertible bonds" (Convertible Bonds), are convertible into fully paid ordinary shares in Telix (Ordinary Shares). The Offering received strong support from eligible investors globally. (PRNewsfoto/Telix Pharmaceutica...
>>> Read more: Telix Successfully Prices A$650 Million Convertible Bonds
>>> Read more: Telix Successfully Prices A$650 Million Convertible Bonds
